How a Marine Veteran with Failed Spinal Fusion Found Relief with Intra-Annular Fibrin Injection

At ValorSpine, we are dedicated to pioneering advanced solutions for debilitating spinal conditions, particularly for those who have exhausted conventional treatments or experienced the complexities of failed spinal surgeries. This case study highlights the journey of a brave Marine veteran who, after enduring years of chronic pain and a previous spinal fusion, discovered renewed hope and significant relief through our innovative biologic disc repair treatment.

Patient Overview

Sergeant Mark Johnson, a 42-year-old Marine Corps veteran, presented to ValorSpine with a complex history of chronic low back pain. Mark had served 12 years in active duty, including multiple combat deployments where he experienced blast exposure and sustained repetitive strain from heavy lifting and combat operations. His service-related injuries initially manifested as severe low back pain, eventually diagnosed as degenerative disc disease with significant annular tears at L4-L5. Despite years of conservative management, including extensive physical therapy and numerous epidural steroid injections, his pain persisted and significantly impacted his quality of life.

At the age of 38, Mark underwent a spinal fusion at L4-L5, a decision made after conventional treatments offered no lasting relief. While the initial recovery from the fusion provided some temporary respite from the immediate L4-L5 pain, he soon began to experience new, insidious pain above and below the fused segment. This phenomenon, known as adjacent segment disease (ASD), is a recognized complication of spinal fusion surgery, where increased stress on the neighboring discs accelerates their degeneration.

Mark’s current pain was primarily localized to his lower back, radiating occasionally into his left hip and thigh, characteristic of discogenic pain originating from his L3-L4 and L5-S1 discs. He described his pain as a constant, dull ache, punctuated by sharp, searing episodes with certain movements or prolonged sitting. His initial pain score was consistently 7-8 out of 10 on a daily basis.

The Challenge

Mark’s primary challenge was persistent, severe back pain stemming from adjacent segment disease at L3-L4 and L5-S1, following his L4-L5 spinal fusion. The L4-L5 fusion, while addressing the initial problem, had inadvertently shifted the biomechanical load to the adjacent discs, leading to accelerated degeneration and new annular tears. This created a complex pain profile, with discogenic pain from two levels now compounding his existing post-surgical discomfort.

He struggled immensely with basic daily activities. Sitting for more than 20 minutes was agonizing, making driving and office work nearly impossible. Standing for prolonged periods exacerbated his symptoms, limiting his ability to engage in hobbies he once loved, such as hiking and spending active time with his children. The chronic pain also took a significant toll on his mental well-being, leading to feelings of frustration, isolation, and a sense of helplessness. His military career had instilled a strong sense of resilience and physical capability, and the inability to maintain a semblance of his former active self was deeply demoralizing. He was contemplating medical retirement, and the prospect of further invasive surgery, specifically a second fusion, loomed large, filling him with dread.

The complexity of his condition—a veteran with service-connected injuries, a history of spinal fusion, and the development of adjacent segment disease—presented a significant diagnostic and treatment challenge. Traditional approaches, especially for failed back surgery syndrome and adjacent segment disease, often involve more extensive, high-risk surgical interventions like additional fusions, which carry their own set of potential complications and recovery burdens.

Previous Treatments Tried

Before presenting at ValorSpine, Mark had undergone an extensive array of treatments, reflecting a multi-year struggle with his spinal pain:

• Spinal Fusion (L4-L5): This was his most significant previous intervention, performed four years prior to his consultation at ValorSpine. While it addressed the immediate L4-L5 issue, it ultimately contributed to his current adjacent segment disease.
• Epidural Steroid Injections (ESIs): Over the past three years, Mark had received six ESIs at various levels (L3-L4, L5-S1) in an attempt to manage his radicular and localized pain. Each injection provided only transient, minimal relief, typically lasting a few weeks at most, before the pain would inevitably return to its baseline severity.
• Physical Therapy: Mark had completed two extensive courses of physical therapy, focusing on core strengthening, flexibility, and posture correction. While he diligently followed the programs, they failed to provide substantial or lasting pain reduction, primarily because the underlying structural damage (annular tears and disc degeneration) remained unaddressed.
• Chiropractic Care: For several years, Mark sought chiropractic adjustments, finding temporary symptomatic relief, but no long-term resolution for his discogenic pain.
• Pain Medications: He had been prescribed various pain medications, including NSAIDs, muscle relaxants, and low-dose opioids. While these offered some symptomatic management, they were not sustainable long-term solutions, came with side effects, and did not address the root cause of his pain.
• Platelet-Rich Plasma (PRP) Injection: Approximately 18 months prior, Mark underwent a PRP injection into one of his symptomatic discs (L5-S1) with the hope of stimulating healing. Unfortunately, this treatment yielded no noticeable improvement in his pain or function.
• Consultation for Revision Surgery: Due to the severity and persistence of his pain, and the diagnosis of adjacent segment disease, Mark had consulted with multiple spine surgeons who had unanimously recommended another fusion surgery, this time at L3-L4, and potentially L5-S1. This prospect filled Mark with apprehension, given his previous experience and the extensive recovery involved in such a major operation. He was actively seeking non-surgical alternatives to avoid further invasive procedures.

Our Approach

ValorSpine’s approach for Sergeant Johnson was centered on our unique biologic disc repair strategy, specifically intra-annular fibrin injection. Recognizing the limitations of his previous treatments—which either failed to address the root cause of disc degeneration and annular tears or led to further complications like adjacent segment disease—we proposed a targeted, minimally invasive, and regenerative solution.

Our comprehensive evaluation included a thorough review of Mark’s medical history, prior imaging (X-rays, MRI scans from before and after his fusion), and a detailed physical examination. Crucially, we performed a discogram, a diagnostic procedure that helps identify which specific discs are pain generators. This test confirmed that his L3-L4 and L5-S1 discs were indeed the primary sources of his current pain, both exhibiting clear evidence of annular tears and degenerative changes. The discogram was critical in pinpointing the exact targets for treatment, preventing unnecessary interventions on non-symptomatic discs.

Our treatment philosophy for Mark was distinct:

1. Precision Diagnosis: Moving beyond general diagnoses to identify the exact, symptomatic annular tears causing discogenic pain.
2. Targeted Biologic Repair: Instead of fusing segments or merely masking pain with steroids, we aimed to facilitate the natural healing of the damaged annular fibers and restore the disc’s integrity using a biologic agent.
3. Minimally Invasive: Performing the procedure percutaneously, meaning through a small needle, thereby avoiding the extensive tissue damage and lengthy recovery associated with open surgery.
4. Regenerative Focus: Utilizing fibrin, a natural protein crucial in the body’s clotting and wound healing processes, to seal the annular tears and encourage the disc to repair itself. This stands in stark contrast to treatments that either remove disc material (discectomy) or permanently immobilize segments (fusion).
5. Patient-Centered Care: Developing a personalized post-procedure rehabilitation plan designed to support the disc’s healing process and gradually restore function, with a keen awareness of Mark’s history as a veteran and his specific physical demands.

This approach offered Mark a genuine alternative to further spinal fusion, addressing the root cause of his discogenic pain in a way that respected the complex biomechanics of his spine and his desire to avoid more surgery.

Treatment Process

Sergeant Mark Johnson’s biologic disc repair procedure was meticulously planned and executed at our state-of-the-art facility. The process began with extensive pre-procedure counseling, where our team fully explained the intra-annular fibrin injection procedure, its mechanism of action, potential risks, and expected recovery timeline. Mark’s active participation in this discussion ensured he felt informed and confident in the chosen path.

The procedure itself was performed in an outpatient setting, under strict sterile conditions, utilizing advanced fluoroscopic (real-time X-ray) guidance to ensure pinpoint accuracy. Moderate sedation was administered to ensure Mark’s comfort throughout the process.

1. Patient Positioning and Anesthesia: Mark was positioned comfortably on his stomach. The skin over his lower back was thoroughly sterilized, and a local anesthetic was administered to numb the injection sites at L3-L4 and L5-S1.
2. Needle Placement: Under continuous fluoroscopic guidance, a specialized needle was carefully advanced towards the outer annulus of the targeted discs (L3-L4 and L5-S1). This precise guidance is crucial to ensure the needle enters the disc space correctly and safely, avoiding sensitive neural structures.
3. Disc Confirmation: A small amount of contrast dye was injected into each disc. This “discogram” confirmed the presence and location of the annular tears, visualizing the leakage of contrast material through the damaged fibers. This step also served as a diagnostic confirmation, often reproducing the patient’s pain, thereby solidifying the disc as a pain generator.
4. Fibrin Injection: Once the precise location of the annular tears was confirmed, a specially prepared fibrin solution was carefully injected directly into the damaged outer annular fibers of both the L3-L4 and L5-S1 discs. The fibrin acts as a biologic sealant, forming a strong, durable clot within the tear. This seal immediately helps to contain the nucleus pulposus and, more importantly, provides a scaffold for the body’s natural healing processes to occur, encouraging the growth of new connective tissue to permanently repair the tear.
5. Post-Procedure Care: After the injection, the needles were removed, and sterile dressings were applied. Mark was monitored for a short period in recovery before being discharged home with specific post-procedure instructions.

The entire procedure was completed in less than two hours. Mark was advised to adhere to a strict post-procedure protocol, including a period of relative rest, avoiding heavy lifting or strenuous activity for several weeks, and gradually reintroducing gentle mobility exercises. This careful adherence to the recovery plan is paramount to allow the fibrin seal to mature and for the disc to begin its healing journey effectively. Our team provided ongoing support and guidance throughout his recovery.

The Results

Sergeant Mark Johnson’s recovery trajectory after his intra-annular fibrin injection at ValorSpine was a testament to the power of biologic disc repair, especially for complex cases like failed back surgery syndrome and adjacent segment disease.

Initial Post-Procedure Period (Weeks 1-3): As expected, Mark experienced some temporary discomfort and stiffness in the treated areas during the first week, which is a normal part of the healing inflammatory response. This was managed with over-the-counter pain relievers and gentle activity. By week three, he noted a subtle but discernible reduction in his baseline pain, particularly the sharp, searing pains he used to experience with movement. His pain score, which had been a consistent 7-8/10, had dropped to an average of 5/10.

Early Recovery (Months 1-3): By the end of month one, Mark reported a moderate improvement, with his daily pain level consistently hovering around 4/10. He found he could sit for longer periods without significant discomfort, extending his tolerance from 20 minutes to nearly an hour. He began incorporating light walking into his daily routine, feeling more stable and confident. At the three-month mark, Mark’s pain had significantly improved to an average of 3/10. The radiating pain into his left hip and thigh had almost entirely resolved. He was able to drive comfortably for longer distances and noticed a substantial improvement in his sleep quality, no longer being woken by pain. He cautiously began to re-engage in some of his former activities, like short hikes with his family, albeit at a reduced intensity.

Sustained Improvement and Functional Restoration (Months 4-12): The most significant improvements were observed between months four and twelve. By month six, Mark’s pain had stabilized at a remarkable 2/10 on most days, a 75% reduction from his initial presentation. He was able to participate in moderate physical activities, including coaching his son’s youth baseball team and performing light yard work—activities that had been unthinkable just a few months prior. The fear of re-injury that had dominated his life had significantly diminished. At his one-year follow-up, Mark reported continued stability in his pain levels and a profound return to function. He had successfully avoided the recommended second fusion surgery, a major victory for him. He was back to hiking regularly, enjoying an active lifestyle, and described his quality of life as drastically improved. He had returned to full-time work, albeit with ergonomic adjustments, feeling productive and engaged once again. The mental burden of chronic pain had lifted, allowing him to reconnect more fully with his family and community.

While full recovery and disc maturation can continue for up to 12-18 months, Mark’s progress within the first year demonstrated the profound impact of biologic disc repair in not only alleviating pain but also in restoring lost function and hope. His case highlights the potential of fibrin disc treatment to provide a durable, non-surgical solution even in complex post-fusion scenarios.

Key Takeaways

Sergeant Mark Johnson’s inspiring journey offers crucial insights into the evolving landscape of spine care, particularly for challenging cases involving prior surgery and persistent discogenic pain:

1. Biologic Disc Repair as a Viable Alternative: For patients suffering from symptomatic annular tears and degenerative disc disease, even those with a history of failed surgical interventions like spinal fusion (and subsequent adjacent segment disease), intra-annular fibrin injection offers a powerful, minimally invasive, and regenerative alternative to repeat surgery. It addresses the fundamental problem of disc structural integrity without the need for additional fusions, which carry their own inherent risks and potential for further complications.
2. Precision Diagnosis is Paramount: The success of Mark’s treatment was heavily reliant on accurate diagnosis. Utilizing diagnostic tools like discography to precisely identify the pain-generating discs and the extent of annular tears ensures that the biologic treatment is applied exactly where it is needed, maximizing efficacy and avoiding unnecessary procedures.
3. Veterans Deserve Advanced Care: Veterans often endure complex, service-connected spinal injuries that are difficult to treat with conventional methods. ValorSpine is committed to providing these heroes with access to cutting-edge biologic solutions that aim to restore function and improve their quality of life, allowing them to remain active and engaged.
4. Avoidance of Further Fusion: For many patients like Mark, the prospect of another spinal fusion surgery is daunting. Biologic disc repair offers a pathway to significant pain reduction and functional improvement, allowing them to avoid more invasive procedures, along with their associated lengthy recoveries and potential for adjacent segment disease.
5. Gradual but Significant Improvement: Healing of disc structures is a biologic process that takes time. Mark’s case illustrates that while immediate dramatic relief may not occur, consistent and significant improvement can be expected over several months, with continued healing up to a year or more. Patient adherence to post-procedure protocols is critical for optimal outcomes.
6. Restoration of Quality of Life: Beyond pain reduction, the ultimate goal of ValorSpine’s treatments is to restore patients’ ability to participate fully in life. Mark’s return to coaching, hiking, and meaningful engagement with his family underscores the profound impact these regenerative treatments can have on overall well-being.

Mark’s story exemplifies ValorSpine’s commitment to offering hope and effective treatment to those who have felt their options were exhausted, proving that even after complex spinal surgeries, a path to lasting relief and restored function is possible through advanced biologic disc repair.

“After my fusion, I honestly thought my life would be nothing but pain and more surgeries. ValorSpine’s fibrin treatment was a game-changer. I’m not just walking; I’m hiking, coaching my son, and living again. They gave me my life back without another major operation.”

— Mark Johnson, Marine Veteran and ValorSpine Patient

If you would like to read more, we recommend this article: How a Marine Veteran with Failed Spinal Fusion Found Relief with Intra-Annular Fibrin Injection